Respiratory Disease News and Research

RSS

Enterprise Therapeutics doses first person with cystic fibrosis in Phase 2 trial for novel therapy ETD001

Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of those suffering from respiratory disease, today announced dosing of the first person with cystic fibrosis (pwCF) in its Phase 2a trial of ETD001.

24 Jul 2024

COVID-19's impact on maternal mortality demands rethink of public health strategies

During the peak of the SARS-CoV-2 pandemic, there was an increase in maternal mortality in Chile. This is confirmed by a natural population experiment based on data from the Department of Health Statistics and Information (DEIS) of the Chilean Ministry of Health. The research was published in PLOS Global Public Health.

23 Jul 2024

Australian welders exposed to high levels of dangerous cancer-causing fumes, study reveals

New Curtin University research has revealed at least 46,000 Australian welders are exposed to high levels of dangerous, potentially cancer-causing fumes at work -; and little is being done to protect them.

21 Jul 2024

Fruit flavored vapes and a nighttime dry cough - what's the connection?

Researchers examined the longitudinal association between exposure to electronic cigarette flavors and nocturnal dry cough.

2 Jul 2024

Enterprise Therapeutics appoints Dr Renu Gupta as Chief Medical Officer and Dr Janet Hammond as Non-Executive Director

Appointments bring additional respiratory and late clinical-stage drug development experience as Company commences Phase 2a clinical trial of its lead asset.

From Enterprise Therapeutics Ltd 17 Jun 2024

Heart-healthy habits keep you biologically young, study shows

A new study in the Journal of the American Heart Association reveals that heart-healthy lifestyle factors are linked to younger biological age and lower cardiovascular disease risk through DNA methylation.

29 May 2024

Heart healthy behaviors may slow biological aging, research shows

The benefit of better heart health may be associated with the positive impact of heart healthy lifestyle factors on biological aging (the age of the body and its cells), according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

29 May 2024

Study confirms face masks' effectiveness in reducing disease transmission, calls for improved public understanding

Researchers reviewed the benefits, practicalities, and harms of masks and masking, finding that masks are effective in reducing respiratory disease transmission despite some adverse effects, and emphasized the need for improved public understanding and policies.

23 May 2024

New Health Blueprint for Southwest Virginia highlights grave health challenges

A sweeping new Health Blueprint for Southwest Virginia highlights the grave health challenges that grip the rural region but also proposes solutions to help residents live longer, healthier lives.

20 May 2024

Breakthrough study shows benefits of diagnosing hidden respiratory diseases

Finding and treating people with undiagnosed asthma or chronic obstructive pulmonary disease (COPD) improved their health and reduced their healthcare visits for respiratory symptoms in the year after diagnosis, according to a world-first clinical trial published in the New England Journal of Medicine.

20 May 2024

Study reveals lung vascular differences in growth-restricted fetuses

If during a pregnancy a fetus grows below normal thresholds, at each week of gestation there is an increased risk that some of its organs may not develop properly, which can adversely affect the baby's health after birth.

17 May 2024

Study reveals soaring rates of adolescent daily e-cigarette use

Electronic vapor products (EVPs), also known as e-cigarettes or vaping devices, have an allure because of their marketed image as a safer alternative to traditional cigarette smoking and for their variety of appealing flavors.

13 May 2024

Early feasibility studies on climate-friendly albuterol inhaler completed

DevPro Biopharma and Bespak have announced the completion of early feasibility studies on DP007, a new formulation of albuterol in a pressurized metered dose inhaler (pMDI) which shows comparable performance to Ventolin® HFA but with a significant reduction in greenhouse gas emissions.

11 May 2024

Can living in flood-prone areas increase your risk of death?

The long-term effects of flooding on mortality.

10 May 2024

Vitamin D receptor polymorphism found to influence COVID-19 severity

Researchers compared SNPs in the vitamin D receptor (VDR) gene between mild and severe COVID-19 patients.

7 May 2024

WHO overturns dogma on airborne disease spread. The CDC might not act on it.

The World Health Organization has issued a report that transforms how the world understands respiratory infections like covid-19, influenza, and measles.

1 May 2024

Progression of subtle CT abnormalities in smokers predicts acute respiratory disease

Smokers who have small abnormalities on their CT scans that grow over time have a greater likelihood of experiencing acute respiratory disease events, according to a new study published today in Radiology, a journal of the Radiological Society of North America.

30 Apr 2024

Study links long-term health risks with burn pit exposure in military veterans

Study links extended deployments at military bases with open burn pits to a higher risk of developing respiratory and cardiovascular diseases, including COPD, asthma, and hypertension in veterans.

28 Apr 2024

Physical activity and BMI related to lung function growth in children

A new study led by the Barcelona Institute for Global Health (ISGlobal), a center supported by the "la Caixa" Foundation, sheds light on the growth of lung function in children.

15 Apr 2024

Study reveals lasting lung damage in tuberculosis survivors

New research being presented at this year's ESCMID Global Congress (formerly ECCMID) in Barcelona, Spain (27-30 April) has found compelling evidence that tuberculosis (TB) can have a lasting impact on the lungs of individuals who have been successfully treated for the disease.

15 Apr 2024